First Page | Meta Content | |
---|---|---|
Document Date: 2012-06-14 10:05:55Open Document File Size: 436,21 KBShare Result on FacebookCityOrlando / /CompanyASPR / MCMs / Global Crisis Management / Business Continuity / The Walt Disney Company / /CountryUnited States / / /EventFDA Phase / M&A / /FacilityThe Keystone Center / /IndustryTermadvisory / intentional chemical / formulations/products / age / chemical threats / study protocols / data collection protocols / expert chemical / /MedicalConditionbotulism / smallpox / pandemic influenza / emerging infectious disease / anthrax / influenza / infectious disease / naturally emerging disease / /OrganizationCongress / National Institute of Health / Enterprise Senior Council / ASPR office of Policy and Planning / Institutional Review Board / federal government / HHS Office / Food and Drug Administration / HHS Biomedical Advanced Research & Development Authority / National Commission on Children and Disasters / Keystone Center / U.S. government / Policy and Planning Division of Medical Countermeasure Strategy & Requirements Roundtable / Food & Drug Administration / ASPR’s office of Preparedness and Emergency Operations / Preparedness & Response office of Policy / Department of Health and Human Services / Centers for Disease Control and Prevention / /PersonEdward Gabriel / Lisa Kaplowitz / Mansoura / Alla Rutstein Bobbitt / /PositionDirector / Division of Medical Countermeasure Strategy and Requirements / Governor / President / Director / Assistant Secretary / EXECUTIVE / Deputy Assistant Secretary of Health / /ProductMCMs / Suggested / /ProvinceOrStateFlorida / /Technologystudy protocols / data collection protocols / drug development / /SocialTag |